Dasatinib | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

Dasatinib
US Patents

European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

Contact Supplier

Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

Contact Supplier

USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

Contact Supplier

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

Contact Supplier

Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

Contact Supplier

Dasatinib

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

68 API Suppliers, 32 USDMF, 5 JDMF, 13 EU WC, 5 KDMF, 21 NDC API, 43 Listed Suppliers, $ API Reference Price

68 API Suppliers
32 USDMF
5 JDMF
13 EU WC
5 KDMF
21 NDC API
43 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

57 Drugs in Development

57 Drugs in Development

INTERMEDIATES

23 Intermediate Suppliers

23 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

619 FDF Dossiers, 61 FDA Orange Book, 278 Europe, 22 Canada, 196 Australia, 15 South Africa, 47 Listed Dossiers

619 FDF Dossiers
61 FDA Orange Book
278 Europe
22 Canada
196 Australia
15 South Africa
47 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 4 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 3 Actylis, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 8 BASF, 10 Corel Pharma Chem, 5 DFE Pharma, 1 Esteem Industries, 1 Finar, 5 Gangwal Chemicals, 4 Ideal Cures, 1 Ingredion Pharma Solutions, 19 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 10 Microlex e.U, 1 Neelkanth MineChem, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 10 Roquette, 6 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

37 Coating Systems & Additives, 31 Fillers, Diluents & Binders, 18 Controlled & Modified Release, 16 Granulation, 14 Thickeners and Stabilizers, 14 Disintegrants & Superdisintegrants, 14 Direct Compression, 9 Lubricants & Glidants, 8 Co-Processed Excipients, 8 Topical, 6 Film Formers & Plasticizers, 5 Empty Capsules, 5 Solubilizers, 4 Chewable & Orodispersible Aids, 4 Vegetarian Capsules, 4 Taste Masking, 3 API Stability Enhancers, 3 Emulsifying Agents, 3 Rheology Modifiers, 2 Coloring Agents, 1 Parenteral

37 Coating Systems & Additives
31 Fillers, Diluents & Binders
18 Controlled & Modified Release
16 Granulation
14 Thickeners and Stabilizers
14 Disintegrants & Superdisintegrants
14 Direct Compression
9 Lubricants & Glidants
8 Co-Processed Excipients
8 Topical
6 Film Formers & Plasticizers
5 Empty Capsules
5 Solubilizers
4 Chewable & Orodispersible Aids
4 Vegetarian Capsules
4 Taste Masking
3 API Stability Enhancers
3 Emulsifying Agents
3 Rheology Modifiers
2 Coloring Agents
1 Parenteral

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 57 News #PharmaBuzz

1 Data Compilation #PharmaFlow
57 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 4 Regulatory FDF Prices, 16 Annual Reports

1 US Medicaid Prescriptions
4 Regulatory FDF Prices
16 Annual Reports

MARKET PLACE

11 APIs, 7 FDF Dossiers

11 APIs
7 FDF Dossiers

PATENTS & EXCLUSIVITIES

96 US Patents, 18 US Exclusivities, 18 Health Canada Patents

96 US Patents
18 US Exclusivities
18 Health Canada Patents

REF. STANDARDS & IMPURITIES

5 Others

5 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 7,860 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

96 All

01 12BRISTOL MYERS SQUIBB

02 84HANDA THERAP

filter Patent Number Reset all filters

96 All

01 67491725

02 1811202778

03 611298356

04 1811324745

05 3612433891

06 612465606

07 67491725*PED

filter API Patent Reset all filters

96 All

01 6Y

02 90Blank

filter FDF Patent Reset all filters

96 All

01 18Y

02 78Blank

filter Expiration Date Reset all filters

96 All

01 62026-03-28

02 62026-09-28

03 842041-01-22

Product Main Page

01

BRISTOL MYERS SQUIBB

PCHi

Not Confirmed

BRISTOL MYERS SQUIBB

PCHi

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-03-28

US Patent Number : 7491725

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 21986

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-03-28

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

BRISTOL MYERS SQUIBB

PCHi

Not Confirmed

BRISTOL MYERS SQUIBB

PCHi

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-03-28

US Patent Number : 7491725

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 21986

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-03-28

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

BRISTOL MYERS SQUIBB

PCHi

Not Confirmed

BRISTOL MYERS SQUIBB

PCHi

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-03-28

US Patent Number : 7491725

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 21986

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-03-28

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

BRISTOL MYERS SQUIBB

PCHi

Not Confirmed

BRISTOL MYERS SQUIBB

PCHi

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-03-28

US Patent Number : 7491725

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 21986

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-03-28

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

BRISTOL MYERS SQUIBB

PCHi

Not Confirmed

BRISTOL MYERS SQUIBB

PCHi

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-03-28

US Patent Number : 7491725

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 21986

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-03-28

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

BRISTOL MYERS SQUIBB

PCHi

Not Confirmed

BRISTOL MYERS SQUIBB

PCHi

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-03-28

US Patent Number : 7491725

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 21986

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-03-28

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

BRISTOL MYERS SQUIBB

PCHi

Not Confirmed

BRISTOL MYERS SQUIBB

PCHi

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-09-28

US Patent Number : 7491725*PED

Drug Substance Claim :

Drug Product Claim :

Application Number : 21986

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-09-28

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

BRISTOL MYERS SQUIBB

PCHi

Not Confirmed

BRISTOL MYERS SQUIBB

PCHi

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-09-28

US Patent Number : 7491725*PED

Drug Substance Claim :

Drug Product Claim :

Application Number : 21986

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-09-28

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

BRISTOL MYERS SQUIBB

PCHi

Not Confirmed

BRISTOL MYERS SQUIBB

PCHi

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-09-28

US Patent Number : 7491725*PED

Drug Substance Claim :

Drug Product Claim :

Application Number : 21986

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-09-28

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

BRISTOL MYERS SQUIBB

PCHi

Not Confirmed

BRISTOL MYERS SQUIBB

PCHi

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-09-28

US Patent Number : 7491725*PED

Drug Substance Claim :

Drug Product Claim :

Application Number : 21986

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-09-28

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2
3
Last

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.